Gastrodin Gastrodia Tuber Extract - China

Gastrodin Gastrodia Tuber Extract Product No: OHI-000156 Active

Ingredient: gastrodin Specification: 80% Test Method HPLC

Gastrodin Gastrodia Tuber Extract Gastrodin Gastrodia Tuber Extract

Latin Name: Tall Gastrodia Tuber Active Ingredient: The drug contains

gastrodin, vanillyalcohol, vanillin, p-hydroxybenzadehyde, 3, 4-

dihydroxybenzaldehyde, palmitic acid Pharmacology Actions: The aqueous

extract or vanillyl alcohol elicited marked decrease of the spontaneous

activity and prolongation of sleep in mice by IP.

Its extract markedly

anta- gonized pentyleneretrazole-induce d clonic con- vulsion in mice by

IP.

Its injection signifi- cantly increased blood flow and reduced peri-

pheral vascular and coronary resistance in mice by IV.

The LD50 of its

extract in mice was 51.4- 61.4g/kg IP.

Actions and Indications: The drug

is used to subdue liver-wind; for the treatment of head- ache, dizziness

and numbness of the limbs, infantile convulsion, epilepsy.

Gastrodin Gastrodia Tuber Extract

Feel free to contact us with all your questions

Company Contact:

• Posted By: Changsha Organic Herb Inc

• Phone: 8673182739236

• Address: A301 International Enterprice Center, No. 188, Hua, Hunan , China

• Email:

• Website: http://www.organic-herb.com

• Business Description: Organic Herb Inc.
  
  (OHI) has been dedicated to the research and development of innovative nutraceutical ingredients since 1993 - Our commitment to science and quality control has earned OHI recognition within the industry as a trusted supplier of ingredients of the highest quality.
  
  OHI is the Developer, Manufacturer, Exporter and Primary Supplier of the most remarkable alternative and complementary herbal health products and raw material available today.
  
  OHI develops and manufactures superior nutraceutical ingredients.
  
  OHI has advanced in home lab as well as professional R&D people swift response to any of your request.
  
  We also co operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase II.